Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check6 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check14 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and specific location details in Seoul, South Korea, while removing various medical terms and classifications related to neoplasms and carcinomas.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check51 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.